This page includes the latest FDA filings for Clovis Oncology Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | CLVS | DUNS 830871518 |
Device Company | Device | Date |
|---|---|---|
| Clovis Oncology, Inc. | Prescription Medication | 2024-02-23 |
| Clovis Oncology, Inc. | Prescription Medication | 2023-11-25 |
| Clovis Oncology, Inc. | Prescription Medication | 2022-12-29 |
| Clovis Oncology, Inc. | Prescription Medication | 2022-06-18 |
| Clovis Oncology, Inc. | Prescription Medication | 2021-10-08 |
| Clovis Oncology, Inc. | Prescription Medication | 2020-10-13 |
| Clovis Oncology, Inc. | Prescription Medication | 2020-05-22 |
| Clovis Oncology, Inc. | Prescription Medication | 2018-04-12 |
| Clovis Oncology, Inc. | Rubraca | 2017-05-01 |
| Clovis Oncology, Inc. | Rubraca | 2016-12-19 |
| Clovis Oncology, Inc. | Rubraca | 2016-12-19 |
CLOVIS ONCOLOGY INC | 0000-00-00 00:00:00 |
| NCAGE Code | 63JV0 | CLOVIS ONCOLOGY, INC.!DBA CLOVIS ONCOLOGY |
| CAGE Code | 63JV0 | CLOVIS ONCOLOGY, INC. CLOVIS ONCOLOGY |
| S.A.M. Registration | 63JV0 [830871518] | CLOVIS ONCOLOGY, INC. CLOVIS ONCOLOGY |
| SEC | 0001466301 | Clovis Oncology, Inc. of DELAWARE |